InsidersTradesSigma
Explore the detailed record of transactions filed by Kenney Richard T, Directeur Médical. Director active across 1 companies, notably Sonnet BioTherapeutics Holdings, Inc.. Cumulatively, 4 filings have been published. Total volume traded: €63k. The latest transaction was filed on 9 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Richard T. Kenney is the Chief Medical Officer at Sonnet BioTherapeutics Holdings, Inc. He oversees the company's medical and research initiatives, contributing to its development in the biopharmaceutical sector.